This content is promotional.
The mAbXmise quantification kits are intended to monitor the concentration of therapeutic monoclonal antibodies (mAbs) in samples from patients treated with these mAbs. The kit is a quantitative assay. The test can be performed on plasma (EDTA, heparin or citrate collection tubes) and serum. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product.
This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.
mAbXmise monoclonal antibodies quantification kits are In Vitro Diagnostic Medical Devices for laboratory professional use and CE-IVD labeled for Europe by BSI. Assay results are intended to be used by healthcare professionals. The kits are designed to perform absolute quantification by LC-MS (Liquid Chromatography – Mass spectrometry) of specific therapeutic monoclonal antibodies (mAbs) in a patient sample. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product. The products are non-refundable. The mAbXmise Kit described has not been cleared by any regulatory entity for diagnostic purposes outside of Europe. Proteomics mAbXmise Kits are not available for sale in all countries.
I am a healthcare professional
Close window if you are not a healthcare professional
The eZYDIAG® quantitative assay for Ricin toxin has been developed by CEA* (Commissariat à l’Énergie Atomique, France).
This kit is based on ELISA (enzyme-linked immunosorbent assay), with specific antibodies developed by CEA.
Promise Proteomics has industrialized the technology, to make it accessible to customers worldwide. Promise holds a commercial license to manufacture and distribute this kit.
The eZYDIAG® kit for Ricin toxin has been developed to detect and quantify this CBRN toxin in clinical samples, thus it is compatible with plasma or serum samples. The kit is intended for use by laboratory professionals, and in laboratories equiped to perform the assay. Results of the analyses should be handled by healthcare professionals.
For more information, please contact us at: contact@promise-proteomics.com
* in English, CEA stands for Atomic Energy Commission.
eZYDIAG® ELISA Ricin is distributed by PROMISE Proteomics,
subsidiary of AGUETTANT, who holds the CE-mark.
Read instructions of eZYDIAG® ELISA Ricin HERE.
The eZYDIAG® ELISA Ricin is an in vitro diagnostic medical device, CE-IVDR certified in Europe by GMED.
The tests results are intended for the specific detection of ricin in human plasma samples.
Before use, please read the instructions supplied with the product carefully.
eZYDIAG®ELISA Ricin is not refundable. eZYDIAG®ELISA Ricin is not available for sale in all countries.
